Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjects.AuthorsHillson, Jan; Mant, Tim; Rosano, Molly; Huntenburg, Carolyn; Alai-Safar, Mehrshid; Darne, Siddhesh; Palmer, Donna; Pavlova, Borislava G.; Doralt, Jennifer; Reeve, Russell; Goel, Niti; Weilert, Doris; Rhyne, Paul W.; Chance, Kamali; Caminis, John; Roach, James; Ganguly, TanmoyPublicationPharmacology Research & Perspectives, 2018, Vol 6, Issue 1, p1ISSN2052-1707Publication typeArticleDOI10.1002/prp2.380